5-vinyl-1-arabinofuranosyluracil has been researched along with sorivudine in 6 studies
| Studies (5-vinyl-1-arabinofuranosyluracil) | Trials (5-vinyl-1-arabinofuranosyluracil) | Recent Studies (post-2010) (5-vinyl-1-arabinofuranosyluracil) | Studies (sorivudine) | Trials (sorivudine) | Recent Studies (post-2010) (sorivudine) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 96 | 8 | 2 |
| Protein | Taxonomy | 5-vinyl-1-arabinofuranosyluracil (IC50) | sorivudine (IC50) |
|---|---|---|---|
| Thymidine kinase | Human herpesvirus 3 strain Dumas | 3.2 | |
| Thymidine kinase | Human alphaherpesvirus 1 (Herpes simplex virus type 1) | 3.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herrmann, G; Lin, JC; Pagano, JS; Reefschläger, J | 1 |
| Färber, I; Herrmann, G; Klinger, C; Reefschläger, J; Thiel, KD; Wutzler, P | 1 |
| Rajcáni, J; Reefschläger, J | 1 |
| Herrmann, G; Reefschläger, J; Thiel, KD; Wutzler, P | 1 |
| Machida, H; Saneyoshi, M; Suzuki, S | 1 |
| Gräf, M; Herrmann, G; Reefschläger, J; Töpke, H; Wutzler, P | 1 |
6 other study(ies) available for 5-vinyl-1-arabinofuranosyluracil and sorivudine
| Article | Year |
|---|---|
Structure-activity relationship between (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BV-araU, V-araU) in inhibition of Epstein-Barr virus replication.
Topics: Antiviral Agents; Arabinofuranosyluracil; Burkitt Lymphoma; DNA, Viral; Dose-Response Relationship, Drug; Herpesvirus 4, Human; Humans; Peptides; Structure-Activity Relationship; Tumor Cells, Cultured; Viral Proteins; Virus Replication | 1992 |
Effect of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil on Epstein-Barr virus antigen expression in P3HR-1 cells: comparison with acyclovir.
Topics: Acyclovir; Antigens, Viral; Antiviral Agents; Arabinofuranosyluracil; Capsid Proteins; Cell Line; Herpesvirus 4, Human; Humans; Uridine | 1987 |
Efficacy of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil against acute herpes simplex virus keratitis and the establishment of latency: comparison with acyclovir and bromovinyldeoxyuridine.
Topics: Acute Disease; Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Chemical Phenomena; Chemistry; Keratitis, Dendritic; Rabbits; Simplexvirus; Uridine | 1987 |
Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir.
Topics: Acyclovir; Animals; Arabinofuranosyluracil; Bromodeoxyuridine; Cells, Cultured; Encephalitis; Female; Foscarnet; Herpes Simplex; Humans; Mice; Phosphonoacetic Acid; Simplexvirus; Uridine; Viral Plaque Assay | 1986 |
Antiviral activity of various 1-beta-D-arabinofuranosyl-E-5-halogenovinyluracils and E-5-bromovinyl-2'-deoxyuridine against salmon herpes virus, Oncorhynchus masou virus (OMV).
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cell Line; Chromatography, High Pressure Liquid; DNA Polymerase II; Fish Diseases; Herpesviridae; Herpesviridae Infections; Nucleic Acid Synthesis Inhibitors; Salmon; Uridine | 1987 |
Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: comparison with (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR).
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Drug Evaluation, Preclinical; Keratitis, Dendritic; Ophthalmic Solutions; Rabbits | 1988 |